An investigation of the efficacy of surgical treatment in patients with cervical myelopathy

Not Applicable

Recruiting

• Conditions: cervical myelopathy

• Registration Number: JPRN-UMIN000033500
• Lead Sponsor: The Jikei University School of Medicine

Brief Summary

Observational study

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-25
• Study Completion: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 125

Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria were as follows: (1) history of cervical surgery; (2) history of cerebral palsy; (3) thoracic spondylotic myelopathy; (4) lumber disc herniation or lumber canal stenosis; (5) cervical radiculopathy; (6) rheumatoid arthritis; (7) destructive spondyloarthritis due to hemodialysis; (8) spinal cord tumor; (9) spinal cord injuries; (10) spinal fusion surgery.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcomes were the clinical evaluation and the image evaluation. We performed these assessments preoperatively and at 3, 6, 12, 18, and 24 months postoperatively.

Secondary Outcome Measures

Name	Time	Method
1) the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ) survey: preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 2)the 36-Item Short Form Health Survey (SF-36): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively 3)Pain Vision PS-2100 (Nipro, Osaka, Japan) the current perception threshold (CPT): preoperatively and at 3, 6, 12, 18, and 24 months postoperatively